TSS
EOLS icon

Two Sigma Securities’s Evolus EOLS Stock Holding History

Two Sigma Securities’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,292
Closed -$75.1K – 1787
2025
Q4 		$75.1K Buy
+11,292
New +$76.5K 0.01% 1016

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Securities's EOLS Position: Q1 2026 in Review

Two Sigma Securities sold out of Evolus (EOLS) in Q1 2026, closing a stake of 11,292 shares — an estimated $75.1K sold.

Two Sigma Securities first reported a position in EOLS in Q4 2025 and held it in 1 quarter. The position peaked at $75.1K in Q4 2025. 147 funds tracked by Wall St. Rank hold EOLS as of Q1 2026.

  • Two Sigma Securities reported no remaining Evolus position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 11,292 Evolus shares in Q1 2026, an estimated $75.1K.
  • Two Sigma Securities first reported a position in Evolus in Q4 2025 and held it in 1 quarter.
  • Two Sigma Securities's Evolus position peaked at $75.1K in Q4 2025.
  • 147 funds tracked by Wall St. Rank held Evolus as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.